Browsing Tag

Aclaris Therapeutics

Aclaris Therapeutics to Participate in the H.C. Wainwright 24th Annual Global…

Eli Pacheco Aug 30, 2022 0

WAYNE, Pa., Aug. 30, 2022 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for…

Health

Aclaris Therapeutics to Participate in the Jefferies Healthcare Conference

Eli Pacheco Jun 2, 2022 0

WAYNE, Pa., June 01, 2022 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for…

Health

Aclaris Therapeutics Announces Publication of Preclinical Research of Zunsemetinib in…

Eli Pacheco Dec 3, 2021 0

WAYNE, Pa., Dec. 03, 2021 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for…

Health

Aclaris Therapeutics to Host Virtual R&D Day on December 7, 2021

Eli Pacheco Nov 19, 2021 0

Investigational New Drug Application for ATI-2138 Allowed WAYNE, Pa., Nov. 18, 2021 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical…

Health

Aclaris Therapeutics to Participate in Upcoming Investor Conferences

Eli Pacheco Aug 28, 2021 0

WAYNE, Pa., Aug. 26, 2021 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for…